Status:
COMPLETED
Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
SARS-CoV 2
Eligibility:
All Genders
18+ years
Brief Summary
A number of clinical features suggest the possibility of dysautonomia in patients infected with SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). At the same time, there is now strong exp...
Detailed Description
In this study, patients will have a continuous recording of their heart rhythm via a holter-ECG throughout their hospitalization.
Eligibility Criteria
Inclusion
- major
- with clinical signs of SARS-CoV-2
- understanding and speaking French fluently to understand the explanations and participate in the study
- who have given their oral consent to participate in the study
- affiliated or entitled to a social security scheme.
Exclusion
- with a history of Parkinson's disease, insulin-dependent or non-insulin-dependent diabetes at a dysautonomic stage or chronic alcoholism at a dysautonomic stage
- with atrial fibrillation on the ECG trace taken at the time of their entry.
- refusing to participate in the study
- intubated prior to inclusion in the study
- that are within the exclusion period of another research protocol
- with a history of head injury, neurological pathology with a brain impact, or serious unstable somatic disease
- patient under guardianship.
- pregnancy woman
Key Trial Info
Start Date :
April 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 18 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04374045
Start Date
April 30 2020
End Date
June 18 2020
Last Update
January 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Hopital nord
Saint-Etienne, France